Physician profile
Pamelia Barclay
NPI 1639340011
$1,537.63
in general payments reported to CMS, 2019-2025
15 companies · $620 in 2025
The $620 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $163 · 2023: $201 · 2024: $443 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.10 | 2022-2024 | |
| Convatec INC. | $189.32 | 2024-2025 | |
| Solventum Corporation | $139.61 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Advanced Oxygen Therapy INC. | $135.00 | 2024 | Topical Oxygen Chamber For Extremities |
| Lifenet Health | $133.14 | 2025 | Theragenesis Wound Matrix |
| Janssen Pharmaceuticals, INC | $130.37 | 2021-2022 | |
| Eisai INC. | $124.77 | 2025 | |
| Boston Scientific Corporation | $115.11 | 2023-2024 | |
| C. R. Bard, INC. & Subsidiaries | $67.51 | 2023 | Purewick Female External Catheter |
| Integra Lifesciences Corporation | $62.07 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Grt US Holding, INC. | $56.00 | 2022 | |
| Tactile Systems Technology INC | $40.27 | 2025 | Nimbl, Flexitouch Plus |
| Alnylam Pharmaceuticals INC. | $31.25 | 2025 | Amvuttra |
| Alkermes, INC. | $23.52 | 2025 | Vivitrol |
| Smith+Nephew, INC. | $20.59 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamelia Barclay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.